Clinical Trial Update: A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC [Phase 1, Phase 2]

View source ↗

Summary

A phase I/II study evaluating a pan-immunotherapy regimen in patients with biliary tract cancer (BTC) is ongoing, with both phase 1 and phase 2 components; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Biliary Tract Cancer (BTC) | Phase 1, Phase 2 | Status: UNKNOWN